Share
- Release Date: 02/05/12 15:16
- Summary: NTA: MLN: MLN NAV $0.9377 as at 30/4/12
- Price Sensitive: No
- Download Document 1.67KB
MLN
02/05/2012 13:16
NTA
REL: 1316 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.9377 as at 30/4/12
MLN NAV $0.9377 as at 30/4/12
Date 30/4/2012 24/4/2012
MLN NAV $0.9377 $0.9161
Share price close $0.78 $0.77
Discount 17% 16%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 30 April 2012 are approximately as
follows:
Biotest (Germany) 6%
Sarin Technologies (Israel) 6%
Stratec Biomedical (Germany) 4%
Orthofix (United States) 4%
02Micro (China) 4%
NB: One of Marlin Global's investments, Ports Design, is currently on a
trading halt due to the delay in reporting its annual results.
Ports Design comprises 4% of the portfolio as at the date of this NAV
announcement.
Another of Marlin Global's investments, Fook Woo Group Limited ("Fook Woo"),
has voluntarily suspended its trading on the Hong
Kong stock exchange since 28 November 2011. Fook Woo comprises 3% of the
portfolio as at the date of this NAV announcement.
BACKGROUND
Marlin Global Limited is a listed investment company investing in smaller
companies that are listed on an approved stock exchange (excluding a stock
exchange in New Zealand or Australia). The investment portfolio is managed by
Fisher Funds Management Limited, a specialist New Zealand investment manager
with a track record of successfully investing in smaller company shares.
Marlin Global Limited began operating in November 2007 when it allotted
103,000,000 shares.
For further information please contact Marlin Global Limited, ph (09) 484
0365
End CA:00222469 For:MLN Type:NTA Time:2012-05-02 13:16:03
